Improving Access to PrEP (HIV Prevention Medication) for People in Underserved Areas of Rio de Janeiro

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15+
SponsorOswaldo Cruz Foundation

About this trial

This study aims to improve access to HIV prevention using pre-exposure prophylaxis (PrEP) among underserved populations in Rio de Janeiro, including gay and bisexual men, transgender women, and sex workers. Despite the proven effectiveness of PrEP, many people at higher risk of HIV face barriers to accessing and continuing this prevention method, especially those living in socially and economically vulnerable communities.

The study will evaluate whether offering PrEP directly in community-based settings-such as non-governmental organizations, mobile health units, and through telehealth and digital tools-can increase its uptake and continued use. Participants who test negative for HIV will be offered daily oral PrEP, along with counseling and follow-up support. Those who test positive will be referred for appropriate treatment.

The main hypothesis is that delivering PrEP in community settings, combined with supportive strategies like mobile health interventions, will be feasible, acceptable, and more effective in reaching and engaging vulnerable populations, ultimately helping to reduce new HIV infections.

Eligibility criteria

Qualifiers

Individuals aged 15 years or older

Gay, bisexual, and other men who have sex with men (MSM)

Transgender women and travestis

Other sexual and gender minorities (SGM)

Disqualifiers

Positive HIV test result at screening or during study participation

Individuals not eligible for PrEP according to Brazilian national guidelines

Trial design

Treatments tested in this trial

  • Oral Pre-Exposure Prophylaxis (PrEP) (Tenofovir Disoproxil Fumarate/Emtricitabine)
  • Community-Based PrEP Delivery Model
  • Telehealth and mHealth Support

Treatment groups

400 Participants
are divided into 1 treatment group

Sponsors and collaborators